Cost impact of expanding a home-based HIV testing programme

Cost impact of expanding a home-based HIV testing programme PharmacoEconomics & Outcomes News 804, p11 - 2 Jun 2018 Cost impact of expanding a home- based HIV testing programme Integrating screening for non-communicable diseases (NCDs) into a home-based HIV testing and counselling (HTC) programme "results in a modest increase in costs with the potential to avert NCD death and disability," report researchers from South Africa and the US. The researchers estimated the incremental costs of integrating screening for NCDs (including diabetes mellitus, hypertension, hypercholesterolaemia and depression) as well as screening for NCD risk factors (including obesity, tobacco and alcohol use) into a home-based HTC programme. The study was conducted in January 2015 in KwaZulu-Natal, South Africa, and involved a cohort of 570 adults with a high prevalence of HIV (33%). The cost analysis showed that home-based integrated HIV-NCD testing and counselling increased programme costs by $US3.95 (42%) per person screened (from $9.36 to $13.31). Personnel costs were the largest cost component, representing 56% of the total costs, followed by supplies (25%), transportation (8%), and building and overhead (5%). The cost analysis also showed that excluding lipid testing (at $1.71 per strip) from NCD screening reduced marginal supply costs by over 80% and overall incremental costs of integrated HIV-NCD screening to 24%. "These cost data build on the sparse economic evidence assessing the value of innovative integrated models of care in low-middle income settings," note the researchers. Golovaty I, et al. Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa. JAIDS : 10 May 2018. Available from: URL: http://doi.org/10.1097/QAI.0000000000001713 803322884 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png PharmacoEconomics & Outcomes News Springer Journals

Cost impact of expanding a home-based HIV testing programme

Free
1 page
Loading next page...
1 Page
 
/lp/springer_journal/cost-impact-of-expanding-a-home-based-hiv-testing-programme-6q15PT3cdA
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
ISSN
1173-5503
eISSN
1179-2043
D.O.I.
10.1007/s40274-018-4975-2
Publisher site
See Article on Publisher Site

Abstract

PharmacoEconomics & Outcomes News 804, p11 - 2 Jun 2018 Cost impact of expanding a home- based HIV testing programme Integrating screening for non-communicable diseases (NCDs) into a home-based HIV testing and counselling (HTC) programme "results in a modest increase in costs with the potential to avert NCD death and disability," report researchers from South Africa and the US. The researchers estimated the incremental costs of integrating screening for NCDs (including diabetes mellitus, hypertension, hypercholesterolaemia and depression) as well as screening for NCD risk factors (including obesity, tobacco and alcohol use) into a home-based HTC programme. The study was conducted in January 2015 in KwaZulu-Natal, South Africa, and involved a cohort of 570 adults with a high prevalence of HIV (33%). The cost analysis showed that home-based integrated HIV-NCD testing and counselling increased programme costs by $US3.95 (42%) per person screened (from $9.36 to $13.31). Personnel costs were the largest cost component, representing 56% of the total costs, followed by supplies (25%), transportation (8%), and building and overhead (5%). The cost analysis also showed that excluding lipid testing (at $1.71 per strip) from NCD screening reduced marginal supply costs by over 80% and overall incremental costs of integrated HIV-NCD screening to 24%. "These cost data build on the sparse economic evidence assessing the value of innovative integrated models of care in low-middle income settings," note the researchers. Golovaty I, et al. Cost of integrating non-communicable disease screening into home-based HIV testing and counseling in South Africa. JAIDS : 10 May 2018. Available from: URL: http://doi.org/10.1097/QAI.0000000000001713 803322884 1173-5503/18/0804-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Jun 2018 No. 804

Journal

PharmacoEconomics & Outcomes NewsSpringer Journals

Published: Jun 2, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off